In vivo rat assay: Bone remodeling and steroid effects on juvenile bone by pQCT quantification in 7 days

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 1 47-1, 2003, Pages

  McHugh, Nansie A ^a   Vercesi, Haydee M ^a   Egan, Robert W ^a   Hey, John A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Animal model; Bone mineral density; Computed tomography; Glucocorticoid; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE GROWTH; BONE MINERAL; BONE REMODELING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG EFFECT; MALE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TIBIA; TRABECULAR BONE;

EID: 0037225603     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00102.2002     Document Type: Article

References (26)

1. Allen HD. Inhaled corticosteroid therapy for asthma in preschool children: Growth issues. Pediatrics 109: 373-380, 2002.
2. Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, and Wilson KB. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 29: 188-193, 2000.
3. Barou O, Valentin D, Vico L, Barbier A, Alexandre C, and Lefage-Proust MH. High-resolution three-dimensional microcomputed tomography detects bone loss and changes in trabecular architecture early: Comparison with DEXA and bone histomorphometry in a rat model of disuse osteoporosis. Invest Radiol 37: 40-46, 2002.
4. Bechtold S, Ripperger P, Muhlbayer D, Truckenbrodt H, Hafner R, Butenandt O, and Schwarz HP. GH therapy in juvenile chronic arthritis: Results of a two-year controlled study on growth and bone. J Clin Endocrinol Metab 86: 5737-5744, 2001.
5. Blodgett FM, Burgin L, Lezzoni D, Gribetz D, and Talbot NB. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status in children. N Engl J Med 254: 636-641, 1956.
6. Boot AM, de Jongste JC, Verberne AA, Pols HA, and de Muinck Keizer-Schrma SM. Bone mineral density and bone metabolism of prepubertal children with asthma after long-term treatment with inhaled corticosteroids. Pediatr Pulmonol 24: 379-384, 1997.
7. Crilly RG, Cawood M, Marshall DH, and Nordin BE. Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women. J R Soc Med 71: 733-736, 1978.
8. Ferretti JL, Gaffuri O, Capozza R, Cointry G, Bozzini C, Olivera M, Zanchetta JR, and Bozzini CE. Dexamethasone effects on mechanical, geometric and densitometric properties of rat femur diaphyses as described by peripheral quantitative computerized tomography and bending tests. Bone 16: 119-124, 1995.
9. Harris M, Hauser S, Nguyen TV, Kelly PJ, Rodda C, Morton J, Freezer N, Strauss BJ, Eisman JA, and Walker JL. Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment. J Paediatr Child Health 37: 67-71, 2001.
10. Hougardy DM, Peterson GM, Bleasal MD, and Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther 25: 227-234, 2000.
11. King CS, Weir EC, Gundberg CW, Fox J, and Isogna KL. Effects of continuous glucocorticoid infusion on bone metabolism in the rat. Calcif Tissue Int 59: 184-191, 1996.
12. Lane NE. An update on glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 27: 235-253, 2001.
13. Lukert BP, Stanbury SW, and Mawer EB. Vitamin D and intestinal transport of calcium: Effects of prednisolone. Endocrinology 93: 718-722, 1973.
14. MacAdams MR, White RH, and Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 104: 648-651, 1986.
15. Morris HG. Growth and skeletal maturation in asthmatic children: Effect of corticosteroid treatment. Pediat Res 9: 579-583, 1975.
16. Muhlbauer RC, Bauss F, Schenk R, Janner M, Bosies E, Strein K, and Fleisch H. BM21.0955, a potent new bisphosphonate to inhibit bone resorption. J Bone Miner Res 6: 1003-1011, 1991.
17. Nishimura J and Ikuyama S. Glucocorticoid-induced osteoporosis: Pathogenesis and management. J Bone Miner Metab 18: 350-352, 2000.
18. Ohyama T, Sato M, Wada Y, and Takahara J. Diverse effects of glucocorticoids on the hypothalamic pituitary axis in rat growth hormone secretion. Endocr J 43, Suppl: S115-S117, 1996.
19. Sampson HW, Gallager S, Lange J, Chondra W, and Hogan HA. Binge drinking and bone metabolism in a young actively growing rat model. Alcohol Clin Exp Res 23: 1228-1231, 1999.
20. Sampson HW and Spears H. Osteopenia due to chronic alcohol consumption by young actively growing rats is not completely reversible. Alcohol Clin Exp Res 23: 324-327, 1999.
21. Schenk R, Eggli P, Fleisch H, and Rosini S. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38: 342-349, 1986.
22. Shen V, Birchman R, Xu R, Lindsay R, and Dempster DW. Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen- and/or dietary calcium- deficient rats. Bone 16: 149-156, 1995.
23. Suzuki Y, Ichikawa Y, Saito E, and Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32: 151-156, 1983.
24. Weinstein RS, Jilka RL, Parfitt AM, and Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 102: 274-282, 1998.
25. Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, and Tattersfield AE. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355: 1399-1403, 2000.
26. Yasumura S. Effect of adrenal steroids on bone resorption inrats. Am J Physiol 230: 90-93, 1976.